1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
(
- Contribution to journal › Article
- 2023
-
Mark
C57Bl/6N mice have an attenuated lung inflammatory response to dsRNA compared to C57Bl/6J and BALB/c mice
(
- Contribution to journal › Article
-
Mark
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study) : A Double-Blind Randomized Controlled Trial
(
- Contribution to journal › Article
- 2022
-
Mark
The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)
(
- Contribution to journal › Article
-
Mark
Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic
(
- Contribution to journal › Article
-
Mark
Airway exposure to urban aerosolized PM2.5 particles induces neuroinflammation and endothelin-mediated contraction of coronary arteries in adult rats
(
- Contribution to journal › Article
-
Mark
Altered viral resistance and tolerance as pathogenic mechanisms of allergic airway inflammation
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
LL-37 and Double-Stranded RNA Synergistically Upregulate Bronchial Epithelial TLR3 Involving Enhanced Import of Double-Stranded RNA and Downstream TLR3 Signaling
(
- Contribution to journal › Article
-
Mark
House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma
(
- Contribution to journal › Article
- 2021
-
Mark
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
2021) European Respiratory Society (ERS) congress 2021(
- Contribution to conference › Poster